2 mg semaglutide to tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options Switch from Semaglutide to Tirzepatide:

Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 996 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits

10 Commandments of Polypharmacy Webinar based on my experiences in clinical practice

December 5, 2025

For an overview of how regulators view this market, see our medical disclaimer

High activity of NNMT is also correlated with lower levels of glucose transporter 4 (GLUT4), which is vital for glucose uptake from the bloodstream into fat and muscle cells